{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:25:42Z","timestamp":1779211542836,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40620-018-00562-2","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:23:31Z","timestamp":1544055811000},"page":"297-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sustained low-efficiency dialysis for metformin-associated lactic acidosis in patients with acute kidney injury"],"prefix":"10.1093","volume":"32","author":[{"given":"Paolo","family":"Greco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-5681","authenticated-orcid":false,"given":"Giuseppe","family":"Regolisti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ferioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Fani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Maccari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Gandolfini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"562_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38:140\u2013149","journal-title":"Diabetes Care"},{"key":"562_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4158\/EP151126.CS","volume":"22","author":"AJ Garber","year":"2016","unstructured":"Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA et al (2016) Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm. 2016 Executive summary. Endocr Pract 22:84\u2013113","journal-title":"Endocr Pract"},{"key":"562_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"key":"562_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2014.19","volume":"87","author":"JD Lalau","year":"2015","unstructured":"Lalau JD, Arnouts P, Sharif A, De Broe ME (2015) Metformin and other antidiabetic agents in renal failure patients. Kidney Int 87:308\u2013322","journal-title":"Kidney Int"},{"key":"562_CR5","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/dom.12974","volume":"19","author":"JD Lalau","year":"2017","unstructured":"Lalau JD, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N (2017) Metformin-associated lactic acidosis (MALA): moving towards a new paradigm. Diabetes Obes Metab 19:1502\u20131512","journal-title":"Diabetes Obes Metab"},{"key":"562_CR6","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.2215\/CJN.10871014","volume":"10","author":"LS Weisberg","year":"2015","unstructured":"Weisberg LS (2015) Lactic acidosis in a patient with type 2 diabetes mellitus. Clin J Am Soc Nephrol 10:1476\u20131483","journal-title":"Clin J Am Soc Nephrol"},{"key":"562_CR7","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1097\/CCM.0000000000001002","volume":"43","author":"D Calello","year":"2015","unstructured":"Calello D, Liu KD, Wiegand TJ, Roberts DM, Lavergne V, Gosselin S et al (2015) Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med 43:1716\u20131730","journal-title":"Crit Care Med"},{"key":"562_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","volume":"61","author":"PM Palevsky","year":"2013","unstructured":"Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61:649\u2013672","journal-title":"Am J Kidney Dis"},{"key":"562_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1053\/j.ajkd.2013.02.350","volume":"61","author":"M James","year":"2013","unstructured":"James M, Bouchard J, Ho J, Klarenbach S, LaFrance JP, Rigatto C et al (2013) Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61:673\u2013685","journal-title":"Am J Kidney Dis"},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2215\/CJN.00510113","volume":"8","author":"E Fiaccadori","year":"2013","unstructured":"Fiaccadori E, Regolisti G, Cademartiri C, Cabassi A, Picetti E, Barbagallo M et al (2013) Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment. Clin J Am Soc Nephrol 8:1670\u20131678","journal-title":"Clin J Am Soc Nephrol"},{"key":"562_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1053\/j.ajkd.2016.12.010","volume":"70","author":"G Regolisti","year":"2017","unstructured":"Regolisti G, Antoniotti R, Fani F, Greco P, Fiaccadori E (2017) Treatment of metformin intoxication complicated by lactic acidosis and acute kidney injury: the role of prolonged intermittent hemodialysis. Am J Kidney Dis 70:290\u2013296","journal-title":"Am J Kidney Dis"},{"key":"562_CR12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2337\/dc09-1284","volume":"33","author":"A Frid","year":"2010","unstructured":"Frid A, Sterner GN, L\u00f6ndahl M, Wiklander C, Cato A, Vinge E et al (2010) Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations. Diabetes Care 33:1291\u20131293","journal-title":"Diabetes Care"},{"key":"562_CR13","unstructured":"D\u2019Argenio DZ, Schumitzky A (1997) Adapt II release 4, user\u2019s guide. In: Biomedical simulations resource. University of Southern California, Los Angeles"},{"key":"562_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","volume":"12","author":"GT Tucker","year":"1981","unstructured":"Tucker GT, Casey C, Phillips PJ, Connor H, Ward JD, Woods HF (1981) Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol 12:235\u2013246","journal-title":"Br J Clin Pharmacol"},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510:542\u2013546","journal-title":"Nature"},{"key":"562_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12915-014-0082-4","volume":"12","author":"A Luengo","year":"2014","unstructured":"Luengo A, Sullivan LB, Heiden MG (2014) Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy. BMC Biol 12:82","journal-title":"BMC Biol"},{"key":"562_CR17","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/dme.13098","volume":"33","author":"D Boucaud-Maitre","year":"2016","unstructured":"Boucaud-Maitre D, Ropers J, Porokhov B, Altman JJ, Bouanick B, Doucet J et al (2016) Lactic acidosis: relationship between metformin levels, lactate concentration and mortality. Diabet Med 33:1536\u20131543","journal-title":"Diabet Med"},{"key":"562_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK et al (2011) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 50:81\u201398","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl2","key":"562_CR19","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/ndt\/gfv100","volume":"30","author":"Guideline development group","year":"2015","unstructured":"Guideline development group (2015) Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR < 45 ml\/min). Nephrol Dial Transpl 30(Suppl2):ii1\u2013i142","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"562_CR20","first-page":"1","volume":"84","author":"K","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 84(3):1\u2013150","journal-title":"Kidney Int"},{"key":"562_CR21","unstructured":"National Institute for Health and Care Excellence. NICE guidelines [NG28] (2015) Type 2 diabetes in adults: management. \n                    https:\/\/www.nice.org.uk\/guidance\/NG28\/chapter\/1-Recommendations\n                    \n                  . Accessed 24 Nov 2017 (Published date: December 2015. Last updated: May 2017)"},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1001\/jama.2014.15298","volume":"312","author":"SE Inzucchi","year":"2014","unstructured":"Inzucchi SE, Lipska J, Mayo H, Bailey CJ, McGuire DK (2014) Metformin in patients with type 2 diabetes and kidney disease, a systematic review. JAMA 312:2668\u20132675","journal-title":"JAMA"},{"key":"562_CR23","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2337\/dc10-2361","volume":"34","author":"KJ Lipska","year":"2011","unstructured":"Lipska KJ, Bailey CJ, Inzucchi SE (2011) Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 34:1431\u20131437","journal-title":"Diabetes Care"},{"key":"562_CR24","first-page":"285","volume":"27","author":"JD Lalau","year":"1989","unstructured":"Lalau JD, Andrejak M, Morini\u00e8re P, Coevoet B, Debussche X, Westeel PF et al (1989) Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int Clin Pharmacol Ther Toxicol 27:285\u2013288","journal-title":"Int Clin Pharmacol Ther Toxicol"},{"key":"562_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1124\/jpet.115.225698","volume":"354","author":"F Xie","year":"2015","unstructured":"Xie F, Ke AB, Bowers GD, Zamek-Glisczynski MJ (2015) Metformin\u2019s intrinsic blood-to-plasma partition ratio (B\/P): reconciling the perceived high in vivo B\/P> 10 with the in vitro equilibrium value of unity. J Pharmacol Exp Ther 354:225\u2013229","journal-title":"J Pharmacol Exp Ther"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/ndt\/12.5.1046","volume":"12","author":"D Heaney","year":"1997","unstructured":"Heaney D, Majid A, Junor B (1997) Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transpl 12:1046\u20131047","journal-title":"Nephrol Dial Transpl"},{"key":"562_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/archinte.1984.00350130235049","volume":"144","author":"JM Chalopin","year":"1984","unstructured":"Chalopin JM, Tanter Y, Besancenot JF, Cabanne JF, Rifle G (1984) Treatment of metformin-associated lactic acidosis with closed recirculation bicarbonate buffered hemodialysis. Arch Intern Med 144:203\u2013205","journal-title":"Arch Intern Med"},{"key":"562_CR28","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/ndt\/gfh337","volume":"19","author":"U Panzer","year":"2004","unstructured":"Panzer U, Kluge S, Kreymann G, Wolf G (2004) Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transpl 19:2157\u20132158","journal-title":"Nephrol Dial Transpl"},{"key":"562_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1525-139X.2006.00123.x","volume":"19","author":"PY Guo","year":"2006","unstructured":"Guo PY, Storsley LJ, Finkle SN (2006) Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. Semin Dial 19:80\u201383","journal-title":"Semin Dial"},{"key":"562_CR30","first-page":"380","volume":"1","author":"A Teutonico","year":"2008","unstructured":"Teutonico A, Libutti P, Lomonte C, Antonelli M, Casucci F, Basile C (2008) Treatment of metformin-associated lactic acidosis with sustained low-efficiency daily dialysis. NDT Plus 1:380\u2013381","journal-title":"NDT Plus"},{"key":"562_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12882-018-0875-8","volume":"19","author":"A Angioi","year":"2018","unstructured":"Angioi A, Cabiddu F, Conti M, Pili G, Atzeni A, Matta V et al (2018) Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long term follow-up. BMC Nephrol 19:77","journal-title":"BMC Nephrol"},{"key":"562_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40620-016-0267-8","volume":"29","author":"A Moioli","year":"2016","unstructured":"Moioli A, Maresca B, Manzione A et al (2016) Metformin associated lactic acidosis (MALA): clinical profiling and management. J Nephrol 29:783\u2013789","journal-title":"J Nephrol"},{"key":"562_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/dme.12959","volume":"33","author":"F Kajbaf","year":"2016","unstructured":"Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Andr\u00e9jak M, Lalau JD (2016) Unexpectedly long half-life of metformin elimination in cases of metformin accumulation. Diabet Med 33:105\u2013110","journal-title":"Diabet Med"},{"key":"562_CR34","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1097\/CCM.0b013e3181a02490","volume":"37","author":"A Seidowsky","year":"2009","unstructured":"Seidowsky A, Nseir S, Houdret N, Fourrier F (2009) Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 37:2191\u20132196","journal-title":"Crit Care Med"},{"key":"562_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13582","author":"AL Chiew","year":"2018","unstructured":"Chiew AL, Wright DFB, Dobos NM et al (2018) \u201cMassive\u201d metformin overdose. Br J Clin Pharmacol. \n                    https:\/\/doi.org\/10.1111\/bcp.13582","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-00562-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-00562-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-00562-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:17Z","timestamp":1777564577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/2\/297\/8328202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-00562-2","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study, involving human participants, were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}